Literature DB >> 3899673

Protective effect by UCB JO28 against histamine and methacholine induced bronchial hyperreactivity.

F P Maesen, J J Smeets, E Baltes, J P Rihoux.   

Abstract

UCB JO28 [( 2-[2-[4-(diphenylmethylene)-1-piperidinyl] ethoxy] ethoxy] acetic acid, hydrochloride) is derived from diphenylmethylene piperidine. Animal experiments have shown that it has spasmolytic properties for smooth muscle, particularly in the bronchi, as well as anti-Hl, anticholinergic and anti-serotonin activities. The degree of protection by JO28 against histamine and methacholine-induced bronchospasm has been investigated in 20 asthmatic patients with serious airways hyper-reactivity. Protection against histamine-induced bronchospasm was almost complete in 11 out of 12 patients, whereas protection against methacholine-induced bronchospasm, although clearly present in seven of eight patients, was less marked.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899673     DOI: 10.1007/bf00544061

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

Review 1.  Postgraduate course presentation. Cromolyn sodium in the treatment of asthma: changing concepts.

Authors:  I L Bernstein
Journal:  J Allergy Clin Immunol       Date:  1981-10       Impact factor: 10.793

2.  Reduction of bronchial hyperreactivity during prolonged allergen avoidance.

Authors:  T A Platts-Mills; E R Tovey; E B Mitchell; H Moszoro; P Nock; S R Wilkins
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

3.  Time course of the bronchoconstriction induced by inhaled histamine and methacholine.

Authors:  A Cartier; J L Malo; P Bégin; M Sestier; R R Martin
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-03

4.  Bronchial responsiveness to histamine: relationship to diurnal variation of peak flow rate, improvement after bronchodilator, and airway calibre.

Authors:  G Ryan; K M Latimer; J Dolovich; F E Hargreave
Journal:  Thorax       Date:  1982-06       Impact factor: 9.139

5.  Measurement of the non-specific threshold stimulus for the bronchial tree by continuous monitoring of respiratory resistance using the oscillation method.

Authors:  M K Tjwa; J J Smeets; L P Jansen; F P Maesen
Journal:  Respiration       Date:  1985       Impact factor: 3.580

6.  Effects of oral H1 and H2 receptor antagonists in asthma.

Authors:  J D Leopold; J P Hartley; A P Smith
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

7.  Airway responsiveness to histamine as a test for overall severity of asthma in children.

Authors:  A B Murray; A C Ferguson; B Morrison
Journal:  J Allergy Clin Immunol       Date:  1981-08       Impact factor: 10.793

8.  Bronchodilating activity of an H1 blocker, chlorpheniramine.

Authors:  V T Popa
Journal:  J Allergy Clin Immunol       Date:  1977-01       Impact factor: 10.793

9.  A comparison of the actions of H1 and H2 antihistamines on histamine-induced bronchoconstriction and cutaneous wheal response in asthmatic patients.

Authors:  R A Nathan; N Segall; A L Schocket
Journal:  J Allergy Clin Immunol       Date:  1981-03       Impact factor: 10.793

10.  Methacholine bronchial challenge in children.

Authors:  G G Shapiro; C T Furukawa; W E Pierson; C W Bierman
Journal:  J Allergy Clin Immunol       Date:  1982-04       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.